These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 27306689)
1. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. Zwicker JI; Karp Leaf R; Carrier M J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689 [TBL] [Abstract][Full Text] [Related]
2. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis. Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875 [TBL] [Abstract][Full Text] [Related]
3. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Mantia C; Uhlmann EJ; Puligandla M; Weber GM; Neuberg D; Zwicker JI Blood; 2017 Jun; 129(25):3379-3385. PubMed ID: 28468796 [TBL] [Abstract][Full Text] [Related]
4. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review. Iyengar V; Agrawal S; Chiasakul T; Tehranchi K; Mcnichol M; Carney BJ; Leader A; Zwicker JI; Patell R J Thromb Haemost; 2024 Feb; 22(2):423-429. PubMed ID: 37866517 [TBL] [Abstract][Full Text] [Related]
5. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors. Mantia C; Zwicker JI Cancer Treat Res; 2019; 179():179-189. PubMed ID: 31317488 [TBL] [Abstract][Full Text] [Related]
6. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors. Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803 [TBL] [Abstract][Full Text] [Related]
7. Intracranial hemorrhage in cancer patients treated with anticoagulation. Weinstock MJ; Uhlmann EJ; Zwicker JI Thromb Res; 2016 Apr; 140 Suppl 1():S60-5. PubMed ID: 27067980 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage. de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398 [TBL] [Abstract][Full Text] [Related]
9. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk? Jo J; Donahue J; Sarai G; Petroni G; Schiff D Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis. Lin RJ; Green DL; Shah GL Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366 [TBL] [Abstract][Full Text] [Related]
11. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis. Yang J; He Z; Li M; Hong T; Ouyang T J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107243. PubMed ID: 37413715 [TBL] [Abstract][Full Text] [Related]
12. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis. Rojas-Hernandez CM; Oo TH; García-Perdomo HA J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333 [TBL] [Abstract][Full Text] [Related]
13. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases. Alvarado G; Noor R; Bassett R; Papadopoulos NE; Kim KB; Hwu WJ; Bedikian A; Patel S; Hwu P; Davies MA Melanoma Res; 2012 Aug; 22(4):310-5. PubMed ID: 22584956 [TBL] [Abstract][Full Text] [Related]
15. Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage. Nguyen T; Sharma M; Crooks P; Patel PV; Bonow RH; Creutzfeldt CJ; Wahlster S Br J Neurosurg; 2022 Apr; 36(2):251-257. PubMed ID: 35343356 [TBL] [Abstract][Full Text] [Related]
16. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients. Diaz M; Jo J Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708 [TBL] [Abstract][Full Text] [Related]
17. The risk of intracranial hemorrhage in glioma patients receiving anticoagulant treatment for venous thromboembolism: a bayesian network meta-analysis. Huo H; Shen S; Yang Y; Zhang H; Wu S; Bi T; Li Y J Thromb Thrombolysis; 2023 Aug; 56(2):333-341. PubMed ID: 37341895 [TBL] [Abstract][Full Text] [Related]
18. Challenges in anticoagulation for patients with brain tumors. Iyengar V; Patell R; Zwicker J Best Pract Res Clin Haematol; 2022 Mar; 35(1):101350. PubMed ID: 36030073 [TBL] [Abstract][Full Text] [Related]
19. Management of venous thromboembolism in patients with glioma. Al Megren M; De Wit C; Al Qahtani M; Le Gal G; Carrier M Thromb Res; 2017 Aug; 156():105-108. PubMed ID: 28624717 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulation for the treatment of venous thromboembolism in patients with brain metastases: a meta-analysis and systematic review. Hunter BD; Minichiello T; Bent S J Thromb Thrombolysis; 2017 Oct; 44(3):392-398. PubMed ID: 28836150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]